Sr Director, RWE Epidemiology Scientist RSV Older Adult, COVID/FLU & Pipeline Lead

Role Summary

This Sr. Director RWE/Epidemiology role will assume a leadership and global role within the Vaccines Real-World Evidence (RWE) and Epidemiology group and serve as team lead for the RSV Older Adult, COVID/FLU & Pipeline Team. The senior director will lead a team of scientists conducting epidemiologic studies and generating real-world evidence on disease burden, vaccine effectiveness, and vaccine impact to support the RSV in older adults, COVID/Flu and Pipeline Vaccines. The incumbent must operate as both a subject matter expert in RWE and epidemiology, as well as strategic thought partner and collaborator with TA Medical colleagues, TA Research Units, and the CMO organization (Regulatory, Safety, DS&A, Medical Enablement & Quality). Evidence generated from these studies will be used to inform vaccine recommendations, utilization and development and licensure of pipeline vaccines.

This is a high-level position that requires skill and experience with field epidemiology, infectious disease surveillance, and database studies. In addition to leading the RSV older adult, COVID/FLU & Pipeline RWE/Epi team, the role will involve managing scientific aspects of complicated long-term projects, interacting with external vaccine experts, and integrating within a multi-disciplinary team at Pfizer. This position is part of a newly formed Vaccines RWE/epidemiology team and will work cross-functionally with collaborators spanning PCV Medical teams, Research Units, and the Chief Medical Officer organization (Medical Evidence Generation, Regulatory, Safety, Data Sciences & Analytics, Medical Enablement & Quality) to design, execute, and disseminate results from studies. This role is accountable for the quality, timeliness, efficiency, and strategic value for RWE/Epi deliverables produced by their team. In this role, the incumbent will cultivate innovation, cross-functional collaboration, and identify opportunities for RWE/Epi to increase the value and success of RSV older adult, COVID/FLU and Pipeline vaccines.

Role Responsibilities

In this role, you will:

• Lead a team of scientists conducting epidemiologic/RWE studies to support RSV older adult, COVID/FLU and Pipeline vaccines.
• Manage a diverse talent pipeline & create a culture of growth and continuous learning
• Stakeholder management: build coalitions & develop strong partnerships across disciplines & geographies to optimize RWE/Epi team’s performance / contribution.  
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
• Provide subject matter expertise and thought leadership to advance Pfizer’s use of RWE/Epi for regulatory purposes and to develop high-value vaccines.
• Partner with MEG Asset Leads to ensure strategic alignment of all RSV older adult, COVID/FLU & Pipeline vaccine RWE/Epi studies.
• Lead epidemiology studies– both field studies involving primary data collection and secondary analyses of real-world data.
• Author and review study protocols, reports, presentations (internally and at scientific conferences), and peer-reviewed manuscripts.
• Provide input to all aspects of study design (e.g., methodology, protocols, analytic plans) for high priority epidemiologic and other scientific studies of importance for RSV older adult, COVID/Flu and Pipeline vaccine issues such as Vaccine Technical Committee recommendations, schedules, public payer options. 
• Work with internal and external experts in statistics and data analysis to analyze and interpret data from RWE/Epi vaccine studies. 
• Be accountable for the collection of epidemiologic and other scientific data necessary for developing vaccine product labels. 

Qualifications

• Advanced degree, including a PhD (preferred) in Epidemiology or a related discipline and 7+ years of relevant experience in the pharmaceutical, academic and/or medical or public health environments; an MD (preferred) with 5+ years of relevant experience as previously stated; or an MPH or another relevant Master’s degree and 10+ years of relevant experience previously stated.
• Subject matter expertise in vaccinology and infectious disease epidemiology.
• Subject matter expertise in at least one of the following areas: RSV, COVID, Influenza
• Strong epidemiological and statistical methods skills used in observational and non-interventional studies.
• At least 7 years of experience in vaccine-related or vaccine-preventable disease related medical/scientific activities including research, clinical development, epidemiologic, and immunization programs.